CoChat

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study

Open access
Patel, Sapna, Abreu, Marconi, Tumyan, Anna, Adams-Huet, Beverley, Li, Xilong, Lingvay, Ildiko · 2019 · BMJ Open Diabetes Research & Care

Abstract

Objective: Medication adherence is impacted by regimen complexity. The SIMPLE (Simple basal Insulin titration, Metformin Plus Liraglutide for type 2 diabetes with very Elevated HbA1c) study compared GLP1RA plus basal insulin (GLP1RA+BI) to basal-bolus insulin (BBI) regimen in participants with very uncontrolled type 2 diabetes mellitus (T2DM). This analysis aimed to evaluate medication adherence to GLP1RA+BI compared with BBI, the effect of adherence on clinical and patient-reported outcomes, and baseline predictors of adherence. Research design and methods: This was an analysis of the SIMPLE study based on prespecified outcome. The study took place in pragmatic, real-world setting. A total of 120 adults with T2DM and HgbA1c≥10% were randomized to detemir plus liraglutide, or detemir plus aspart before each meal; 6-month follow-up. The main outcomes evaluated were: adherence, HgbA1c, weight, quality of life, and hypoglycemia. Adherence rate was calculated for each study medication at each follow-up visit; participants were classified as ≥80% or <80% adherent. Result: A higher percentage of participants in the GLP1RA+BI compared with the BBI group had ≥80% adherence to detemir (59.3% vs 35.7%, p=0.02) as well as liraglutide versus aspart (57.4% vs 30.4%, p=0.007). Higher age was predictive of ≥80% adherence (OR per 5-year increment=1.48, 95% CI 1.09 to 2.0, p=0.01). Higher adherence led to greater improvement in HbA1c and weight in both groups. Treatment with GLP1RA+BI compared with BBI led to greater improvement in HbA1c, weight, and quality of life and lower risk of hypoglycemia even after adjusting for the difference in adherence between groups. Conclusions: Adherence was higher with the simplified regimen of GLP1RA+BI compared with BBI. Greater adherence to the simpler regimen amplified the treatment effect on HbA1c, weight, quality of life, and risk of hypoglycemia, yet statistically significant greater benefits were noted even when adjusted for adherence. Trial registration number: NCT01966978

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjdrc-2019-000761

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Baseline characteristics as predictors of ≥80% adherence. The units for the baseline variables associated with the ORs for adherence ≥80% are age per 5 years, median income per $10 000, insulin TDD/kg per 0.1 unit, weight per 5 kg and HbA1c per 1%. TDD, total daily dose.
Figure 1 Baseline characteristics as predictors of ≥80% adherence. The units for the baseline variables associated with the ORs for adherence ≥80% are age per 5 years, median income per $10 000, insulin TDD/kg per 0.1 unit, weight per 5 kg and HbA1c per 1%. TDD, total daily dose.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 69

Metadata

Authors
Patel, S., Abreu, M., Tumyan, A., Adams-Huet, B., Li, X., & Lingvay, I.
Affiliations
  • Endocrinology, Diabetes and Metabolism, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Lingvay, Ildiko
Venue
BMJ Open Diabetes Research & Care
Publisher
BMJ
Published
2019-11
Volume
7
Issue
1
Pages
e000761
ISSN
2052-4897 (ISSN-L)
OpenAlex
W2990909872
Cited by
56
References
28
Citations by year
2026: 7 · 2025: 7 · 2024: 11 · 2023: 9 · 2022: 10 · 2021: 9 · 2020: 3
FWCI
5.66
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Novo Nordisk
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
medication adherence, type 2 diabetes, GLP-1 receptor agonists, liraglutide, basal insulin, detemir, multiple daily insulin injections, HbA1c, weight, quality of life, hypoglycemia, predictors of adherence, patient-reported outcomes, real-world evidence, pragmatic trials
MeSH terms
Liraglutide, Blood Glucose, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Prognosis, Prospective Studies, Quality of Life, Biomarkers, Drug Monitoring, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study. https://app.cochat.ai/papers/10.1136/bmjdrc-2019-000761
The paper
Patel, S., Abreu, M., Tumyan, A., Adams-Huet, B., Li, X., & Lingvay, I. (2019). Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2019-000761

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.